US Pharma MarketingThe post Median Technologies receives CE marking for eyonis LCS appeared first on Medical Device Network.
Median Technologies receives CE marking for eyonis LCS
Median Technologies has received CE marking for its eyonis LCS, an AI-based Software as a Medical Device, under the European Medical Device Regulation. The CE marking by GMED recognises compliance with patient safety and clinical efficacy for Class IIb devices. eyonis LCS supports clinicians in detecting and characterising lung nodules on LDCT scans to aid diagnosis, risk stratification, management. Credit: NMK-Studio/Shutterstock.com. Median Technologies has received CE marking for its eyonis LCS, an AI-based Software as a Medical Device, under the European Medical Device Regulation (MDR 2017/745). The designation enables the company to commercialise eyonis LCS across the European Economic Area.…
Median Technologies has received CE marking for its eyonis LCS, an AI-based Software as a Medical Device, under the European Medical Device Regulation.
Source: Medical Device Network